# FDA Inspection 1229261 - Northeast Laboratories, Inc. - January 11, 2024

Source: https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/e31b6bf7-2f63-417f-b030-b22120ec14bf
Source feed: FDA_Inspections

> FDA Inspection 1229261 for Northeast Laboratories, Inc. on January 11, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229261
- Company Name: Northeast Laboratories, Inc.
- Inspection Date: 2024-01-11
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1006525 - 2017-03-29](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/3f5a1487-d4ea-4559-a8b5-8e94fb9f1696)
- [FDA Inspection 755765 - 2011-12-02](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/bd23511e-0cff-43fd-9885-4c57530d26b9)
- [FDA Inspection 643538 - 2010-02-04](https://www.keypedia.com/records/fda_inspections/northeast-laboratories-inc/e0ce410a-034c-4a5a-8430-89819c11cbb5)

Company: https://www.keypedia.com/companies/northeast-laboratories-inc/654f5a93-eab8-4f03-8318-d7fff80e9523

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
